MCB Accepts, published online ahead of print on 14 July 2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thillainadesan, G.
Right arrow Articles by Torchia, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thillainadesan, G.
Right arrow Articles by Torchia, J.

 Previous Article  |  Next Article 

Mol. Cell. Biol. doi:10.1128/MCB.00246-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Genome analysis identifies the p15ink4b tumour suppressor as a direct target of the ZNF217/Corest complex

Gobi Thillainadesan, Majdina Isovic, Esther Loney, Joseph Andrews, Marc Tini, and Joseph Torchia*

Dept. of Oncology, London Regional Cancer Program and the Lawson Health Research Institute Dept. of Biochemistry, Dept. of Physiology and Pharmacology, The University of Western Ontario, London, Ontario, Canada

* To whom correspondence should be addressed. Email: jtorchia{at}uwo.ca.


arrow
Abstract

The ZNF217 oncoprotein is a constituent of a core transcriptional complex that includes CoREST, histone deacetylase 1/2 (HDAC 1/2), lysine demethylase 1 (LSD1) and the C terminal binding protein 1/2 (CtBP 1/2). We have combined genome wide expression profiling and chromatin immunoprecipitation with directed selection and ligation (ChIP-DSL) to identify a subset of genes directly regulated by ZNF217. Our results establish p15ink4b as a direct target of the ZNF217 complex. Downregulation of ZNF217 in MCF7 breast cancer cells resulted in a dramatic increase in p15ink4b expression and coincided with increases in dimethylation of H3-K4 and surprisingly, a decrease in K9/K14-H3 acetylation. Stimulation of HaCaT cells with TGF{beta} resulted in a release of ZNF217 and a concomitant binding of SMAD2 to the proximal promoter, which preceded increases in ink4b protein expression. Furthermore, the changes in chromatin marks at the p15ink4b promoter, following TGF{beta} stimulation were similar to those observed following ZNF217 downregulation. Collectively, these results establish the ZNF217 complex as a novel negative regulator of the p15ink4b gene and may consititute an important link between amplification of ZNF217 and the loss of TGF{beta} responsiveness in breast cancer.




This article has been cited by other articles:

  • Chinnadurai, G. (2009). The Transcriptional Corepressor CtBP: A Foe of Multiple Tumor Suppressors. Cancer Res. 69: 731-734 [Abstract] [Full Text]